Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic Adapalene/Benzoyl Peroxide vs Epiduo Forte in Acne
NCT02651220Phase 3Completed
- Sponsor
- Allergan
- Start
- Nov 2015
- Primary completion
- Apr 2016
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of adapalene + benzoyl peroxide in acne vulgaris (3 arms), sponsored by Allergan. Primary endpoints: Percent Change From Baseline to Week 12 in the Number of Inflamed Lesions and Percent Change From Baseline to Week 12 in the Number of Non-inflamed Lesions. Started Nov 2015; status: completed.
02
Drugs
adapalene + benzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02651220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02651220.